Critical Care (Jun 2020)
Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
Abstract
Trial registration ChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registered
Critical Care (Jun 2020)
Trial registration ChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registered